Effects of single, double or triple combinations of octreotide, galanin and serotonin on a human pancreatic cancer cell line

Histology and Histopathology

Volumn 20, Issue 2, 2005, Pages 537-541

  Tjomsland, V ^a   El Salhy, Magdy ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Galanin; Octreotide; Pancreatic cancer; Serotonin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AVIDIN; BIOTIN; EPIDERMAL GROWTH FACTOR; GALANIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OCTREOTIDE; PROTEIN ANTIBODY; SEROTONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EXPOSURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PANCREAS CANCER; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG THERAPY, COMBINATION; EPIDERMAL GROWTH FACTOR; GALANIN; HUMANS; OCTREOTIDE; PANCREATIC NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROLIFERATING CELL NUCLEAR ANTIGEN; SEROTONIN;

EID: 16344384104     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. El-Salhy M. (2004). Comparison between triple therapy with octreotide, galanin and serotonin and 5-fluorouracil/leucovorin, and sequential treatment with both, on human colon cancer. Oncol. Rep. 11, 1161-1168.
2. El-Salhy M. (2005). Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line implanted in mice: comparison between different routes of administration. Histol. Histopathol. 20, 19-25.
3. El-Salhy M. and Dennerqvist V. (2004). Effects of triple therapy with octreotide, galanin and serotonin on liver metastasis of human colon cancer in xenografts. Oncol. Rep. 11, 1177-1182.
4. El-Salhy M. and Starefeldt A. (2003). Direct effects of octreotide, galanin and serotonin on human colon cancer cell. Oncol. Rep. 10, 1723-1728.
5. El-Salhy M. and Sitohy B. (2002). Triple therapy with octreotide, galanin and serotonin induces necrosis and increases apoptosis of rat colon carcinoma. Regul. Pept. 108, 55-62.
6. El-Salhy M., Mahdavi J. and Norrgård Ö. (1998). Colonic endocrine cells in patients with carcinoma of the colon. Eur. J. Gastroenterol. Hepatol. 10, 517-522.
7. El-Salhy M., Sitohy B. and Norrgård Ö. (2003). Triple therapy with octreotide, galanin and serotonin reduces the size and blood vessel density and increase apoptosis in rat colon carcinoma. Regul. Pept. 111, 145-152.
8. El-Salhy M., Tjomsland V. and Theodorsson E. (2004). Effects of triple treatment with octreotide, galanin and serotonin on a human pancreas cancer cell line in xenografts. Submitted.
9. Friess H., Kleeff J., Fischer L., Muller M. and Buchler M.W. (2003). Surgical standard therapy for cancer of the pancreas. Chirurg 74, 183-190.
10. Hejna M., Schmidinger M. and Raderer M. (2002). The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann. Oncol. 13, 653-668.
11. Kerr J., Wexler R., Mousa S., Robinson C., Wexler E., Mohamed S., Voss M., Devenny J., Czermiak A. Jr and Slee A. (1999). Novel small molecule of alpha v integrin antagonists: comparative anticancer efficacy with known angiogenesis inhibitors. Anticancer Res. 19, 959-968.
12. Kikutsuji T., Harada M., Tashiro S., Li S., Moritani M., Ymaoka T. and Itakura M. (2000). Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers. J. Hepatobiliary. Pancreat. Surg. 7, 496-503.
13. Linder S. (1997). Assement of diagnostic and prognostic factors in pancreatic duct carcinoma. Stockholm University, Department of Surgery, Stockholm Söder Hospital. And the Department of Surgery and Pathology, Karolinska Institute, Stockholm, Sweden. Academic dissertation.
14. Lowenfels A.B. and Maisonneuve P. (2002). Epidemiologic and etiologic factors of pancreatic cancer. Hematol. Oncol. Clin. North Am. 16, 1-16.
15. Sitohy B. and El-Salhy M. (2003). Comparison between triple and double therapy of octreotide, galanin and serotonin on rat colon carcinoma. Histol. Histopathol. 18, 103-110.
16. Sohn T.A., Yeo C.J., Cameron J.L., Koniaris L., Kaushal S., Abrams R.A., Sauter P.K., Coleman J., Hruban R.H. and Lillemoe K.D. (2000). Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J. Gastrointest. Surg. 4, 567-579.
17. Weckbecker G., Tolcsvai L., Liu R. and Bruns C. (1993). Preclinical studies on the anticancer activity of somatostatin analogue octreotide (SMS 201-995). Digestion 54, 98-103.
18. Wenger F.A., Kilian M., Mautsch I., Jacobi C.A., Steinert A., Peter F.J., Guski H., Schimke I. and Muller J.M. (2001). Influence of octreotide on liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters. Pancreas 23, 266-272.